Brazil’s healthcare capabilities are increasingly extending beyond its domestic market. While the country’s large population provides a substantial foundation for clinical expertise and healthcare innovation, a growing number of Brazilian capabilities have the potential to serve patients, providers and health systems across Latin America and other international markets. This internationalization is taking place through several interconnected channels.

Health technology and digital health represent one of the most scalable avenues. Brazil has developed a growing ecosystem of digital health companies working across telemedicine, health management, diagnostics and healthcare platforms. As these companies expand into Latin American markets, they provide an opportunity to export healthcare solutions without requiring the physical expansion of hospitals and clinical infrastructure. International acceleration initiatives, including StartOut Brasil, have also supported Brazilian startups seeking to enter foreign markets.

Specialized clinical services provide a second avenue. Leading institutions such as Hospital Israelita Albert Einstein and Hospital Sírio-Libanês have developed internationally recognized capabilities and attract patients seeking complex medical care. Brazil’s concentration of specialist physicians and advanced hospitals, particularly in major urban centers, creates a foundation for expanding cross-border patient flows. International academic partnerships and the mobility of Brazilian clinical specialists can further strengthen this network of expertise. 

A third avenue is the internationalization of clinical expertise. Healthcare capabilities do not need to cross borders only through patients. Physicians, surgeons, researchers and healthcare managers can also transfer knowledge through training programs, academic partnerships, clinical collaborations and specialist exchanges. For Brazil, this could provide a mechanism to extend its expertise in selected subspecialties across neighboring health systems while strengthening regional professional networks.

The fourth avenue is pharmaceutical and medical technology trade. Brazil has an established pharmaceutical and medical products industry and exports selected healthcare products to international markets. At the same time, the country remains dependent on imports for many sophisticated medical technologies and devices. This creates a dual opportunity: strengthening domestic capabilities in high-value health technologies while expanding the international market for products in which Brazilian firms are already competitive. These avenues point to a broader shift in how Brazil can approach healthcare internationalization.

The objective does not need to be the creation of a conventional medical tourism industry. Instead, Brazil could pursue a multi channel model of healthcare exports, combining patient flows, digital services, clinical expertise, education, technology and selected healthcare products.

This approach would be particularly relevant for Latin America. Geographic proximity, cultural connections, shared language in many markets, and existing professional networks can reduce some of the barriers associated with cross-border healthcare. Brazil’s relatively advanced clinical capabilities could therefore complement healthcare systems in neighboring countries where access to highly specialized services remains limited. 

Subspecialty care could provide an important entry point.

Complex oncology, cardiovascular intervention, neurosurgery, transplantation, advanced orthopedics, reproductive medicine, and other high-complexity services require concentrated expertise and sophisticated infrastructure. These are areas where Brazil’s leading institutions can potentially develop a regional value proposition based on clinical depth rather than volume.

However, international expansion will require more than clinical capability. Brazil will need stronger international accreditation, transparent clinical outcomes, referral networks, cross-border payment mechanisms, coordinated patient journeys, and appropriate regulatory frameworks. Digital infrastructure and international partnerships can help reduce these barriers, but institutional trust will remain central. The opportunity is therefore to move from exporting healthcare products and treating international patients toward exporting healthcare capabilities themselves.

For Brazil, this could create a new dimension of the health economy, one in which hospitals become regional centers of excellence, specialists become sources of international expertise, digital health companies become cross-border service providers, and selected pharmaceutical and medical technology companies compete in global markets.

The strategic question is no longer whether Brazil has the capabilities to participate in international healthcare. It is how effectively those capabilities can be organized, connected, and taken beyond the country’s borders.